Open access · CC-BY
via OpenAlex
POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo
Christian Velling Thorup, Chris Nørgaard Agerbo Jeppesen, Thomas Jensen, Andreas Bugge Tinggaard, Christian Lodberg Hvas, Charlotte Lock Rud, Maria Kreiberg Skou, Janne Kaergaard Mortensen, Fulvio Reggiori, Jörn Dengjel, Jakob Wang, Jean Farup, Niels Jessen, Won Yong Kim, Henrik Wiggers
Trials · 2025 · ▲ 5 citations
Mitochondrial dysfunction
Chronic inflammation
Disabled macroautophagy
Caloric restriction
Spermidine
Exercise
Human
Randomized controlled trial
Preclinical / animal
Abstract
Coronary artery disease (CAD) remains a major cause of morbidity and mortality. Caloric restriction(definition) promotes cardiovascular health but is difficult to sustain. Spermidine, a naturally occurring polyamine and caloric-restriction mimetic, has been linked to improved longevity in epidemiological studies and shown to enhance autophagy(definition), mitochondrial function, and cardiovascular ageing in preclinical models. This trial will investigate whether high-dose spermidine improves cardiac remodelling, exercise capacity, muscle mass, and systemic inflammation in elderly patients with CAD. This is a single-centre, randomised, double-blind, placebo-controlled, superiority trial at Aarhus University Hospital, Denmark. We have randomised 187 patients aged ≥ 65 years with CAD (prior coronary artery revascularisation or myocardial infarction ≥ 3 months prior to screening) and preserved left ventricular ejection fraction (> 40%) in a 1:1 ratio to receive either 24 mg/day spermidine or placebo for 48 weeks. Participants, investigators, outcome assessors, and data analysts will remain blinded until completion of the analysis of all primary endpoints. Analyses will follow the intention-to-treat principle. The trial is powered to detect between-group differences in four co-primary endpoints: (1) left ventricular mass (g) by cardiac magnetic resonance imaging, (2) peak oxygen consumption (mL·kg⁻ 1 ·min⁻ 1 ) by cardiopulmonary exercise testing, (3) appendicular lean mass (g) by dual-energy X-ray absorptiometry, and (4) high-sensitivity C-reactive protein (mg/L). Secondary outcomes include 24-h ambulatory blood pressure, arterial stiffness, physical performance, muscle strength, daily physical activity, quality of life, cognitive function, dietary spermidine intake, and spermidine levels in plasma and skeletal muscle. Safety monitoring includes laboratory testing, telephone interviews and adverse event recording. This is the first trial to investigate the cardiovascular and metabolic benefit from a high-dose spermidine treatment in patients with CAD. The findings will provide important insights into the therapeutic potential of spermidine. ClinicalTrials.gov identifier NCT06186102 (first posted 12 June 2023). Participant enrolment began on 4 January 2024, and trial completion is anticipated in August 2026.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13063-025-09176-z
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Thorup, C.V., Jeppesen, C.N.A., Jensen, T., Tinggaard, A.B., Hvas, C.L., Rud, C.L., Skou, M.K., Mortensen, J.K., Reggiori, F., Dengjel, J., Wang, J., Farup, J., Jessen, N., Kim, W.Y., & Wiggers, H. (2025). POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo. <em>Trials</em>. https://doi.org/10.1186/s13063-025-09176-z
Vancouver
Thorup CV, Jeppesen CNA, Jensen T, Tinggaard AB, Hvas CL, Rud CL, et al. POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo. Trials. 2025. doi:10.1186/s13063-025-09176-z.
BibTeX
@article{christian2025POLYam,
title = {POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo},
author = {Christian Velling Thorup and Chris Nørgaard Agerbo Jeppesen and Thomas Jensen and Andreas Bugge Tinggaard and Christian Lodberg Hvas and Charlotte Lock Rud and Maria Kreiberg Skou and Janne Kaergaard Mortensen and Fulvio Reggiori and Jörn Dengjel and Jakob Wang and Jean Farup and Niels Jessen and Won Yong Kim and Henrik Wiggers},
journal = {Trials},
year = {2025},
doi = {10.1186/s13063-025-09176-z},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Sahlgrenska University Hospital 2021
Open access · US-GOV
Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease and the Significance of Removing the Colon
Manchester Metropolitan University 2026
Open access · US-GOV
Surveying the Dietary Intake, Physical Activity Patterns, Muscle Strength and Morphology of Adults With Inclusion Body Myositis
Jurnal Gizi dan Pangan 2024
Open access · CC-BY
Effects of Time-Restricted Eating on Cardiometabolic and Cardiovascular Health: Study Protocol (TRES)
Epirium Bio Inc. 2027
Open access · US-GOV
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MF-300 in Subjects With Age-related Sarcopenia
Cell Reports Medicine 2022
Open access · CC-BY
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
Massimo Venturelli, PhD 2022
Open access · US-GOV